Celularity (CELUW) Operating Expenses (2019 - 2025)
Celularity (CELUW) reported Operating Expenses of $26.2 million for Q4 2025, down 4.56% year-over-year from $27.4 million in Q4 2024, and up 43.87% quarter-over-quarter from $18.2 million in Q3 2025.
Celularity (CELUW) Operating Expenses (2019 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of Operating Expenses data on file, last reported at $26.2 million in Q4 2025.
- Operating Expenses for Q4 2025 came in at $26.2 million, down 4.56% year-over-year; the trailing twelve-month figure through Dec 2025 was $87.9 million (down 5.1% YoY), and the FY2025 annual result was $87.9 million, down 5.1% from the prior year.
- Operating Expenses rose to $26.2 million in Q4 2025 per CELUW's latest filing, from $18.2 million in the prior quarter.
- Over five years, Operating Expenses peaked at $103.0 million in Q3 2023 and troughed at -$13.4 million in Q4 2022.
- A 5-year average of $28.5 million and a median of $22.0 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2021 and 2022: Operating Expenses surged 30542.6% in 2021, then slumped 167.43% in 2022.
- A 5-year view of Operating Expenses shows it stood at $19.8 million in 2021, then tumbled by 167.43% to -$13.4 million in 2022, then surged by 90.99% to -$1.2 million in 2023, then soared by 2378.64% to $27.4 million in 2024, then fell by 4.56% to $26.2 million in 2025.
- Business Quant data shows CELUW's Operating Expenses at $26.2 million in Q4 2025, $18.2 million in Q3 2025, and $21.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Celularity | - | - | -3.27 Mn | 26.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.16 Mn |
| Sep 30, 2025 | 18.18 Mn |
| Jun 30, 2025 | 21.60 Mn |
| Mar 31, 2025 | 21.91 Mn |
| Dec 31, 2024 | 27.41 Mn |
| Sep 30, 2024 | 20.82 Mn |
| Jun 30, 2024 | 22.29 Mn |
| Mar 31, 2024 | 22.06 Mn |
| Dec 31, 2023 | -1.20 Mn |
| Sep 30, 2023 | 103.04 Mn |
| Jun 30, 2023 | 45.41 Mn |
| Mar 31, 2023 | 67.81 Mn |
| Dec 31, 2022 | -13.36 Mn |
| Sep 30, 2022 | 9.78 Mn |
| Jun 30, 2022 | -399,000.00 |
| Mar 31, 2022 | 47.55 Mn |
| Dec 31, 2021 | 19.81 Mn |
| Sep 30, 2021 | -276,000.00 |
| Jun 30, 2021 | 63.81 Mn |
| Mar 31, 2021 | 47.06 Mn |